The ANCHOR Study has halted recruitment. The study is no longer enrolling new participants. The ANCHOR Study has collected enough data to demonstrate that treatment of anal HSIL is effective in reducing the incidence of anal cancer in women and men living with HIV. All current participants are encouraged to contact their local study site for more details. If there are additional questions or concerns, please contact us by phone or on-line.
Contact Information for this study: